Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances
Research output: Contribution to journal › Journal article › Research › peer-review
This article highlights recent advances in our understanding of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) physiology and their various sites of action beyond the incretin effect.
| Original language | English |
|---|---|
| Journal | Current Opinion in Endocrinology, Diabetes and Obesity |
| Volume | 17 |
| Issue number | 1 |
| Pages (from-to) | 57-62 |
| Number of pages | 6 |
| ISSN | 1752-296X |
| Publication status | Published - 1 Feb 2010 |
- Adipocytes, Animals, Bone and Bones, Cardiovascular Physiological Processes, Central Nervous System, Gastric Inhibitory Polypeptide, Glucagon-Like Peptide 1, Humans, Insulin-Secreting Cells, Lipid Metabolism, Peripheral Nervous System, Receptors, Gastrointestinal Hormone
Research areas
ID: 33940651